AusGov.info

What's hot & what's not?

Federal Budget Data

You are currently displaying the option highlighted by the icon below. To display options mouse over the icon then click to select.

Each result begins with a chart showing totals for each year of budget data. Click on the point to drill down.

Health

Annual Report	Strategic Plan	Budget Statement	2018-19 Staff
			54

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	Ordinary annual services
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$3,860,000 3.86M	$3,404,000 3.40M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	to National Blood Authority Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$-3,860,000 -3.86M	$-3,404,000 -3.40M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	to National Managed Fund Blood and Blood Products Special Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$0,000 0.00M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	National Blood Authority Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$1,171,220,000 1,171.22M	$1,253,439,000 1,253.44M	$1,333,794,000 1,333.79M	$1,445,933,000 1,445.93M	$1,578,877,000 1,578.88M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	National Managed Fund Blood and Blood Products Special Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$0,000 0.00M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	Departmental appropriation
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$5,590,000 5.59M	$5,682,000 5.68M	$5,686,000 5.69M	$5,531,000 5.53M	$5,562,000 5.56M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	to National Blood Authority Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$-5,590,000 -5.59M	$-5,682,000 -5.68M	$-5,686,000 -5.69M	$-5,531,000 -5.53M	$-5,562,000 -5.56M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	National Blood Authority Account
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$9,457,000 9.46M	$9,631,000 9.63M	$9,638,000 9.64M	$9,409,000 9.41M	$9,460,000 9.46M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	Expenses not requiring appropriation in the budget year
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$418,000 0.42M	$392,000 0.39M	$592,000 0.59M	$559,000 0.56M	$559,000 0.56M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection

	Health Portfolio
Agency	National Blood Authority
Program	National Blood Agreement Management
Component	Operating deficit surplus
Outcome	Outcome 1: Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements.

$1,784,000 1.78M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M	$0,000 0.00M
2017 Year to date	2018 May budget	2019 Estimate	2020 Projection	2021 Projection